Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
- Posted on October 11, 2024
- By CNBC
- 1 Views
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.
